Sort
11,323 grants matching “glioblastoma”
TRANSLATIONAL CLINICAL TRIALS FOR PRIMARY CNS TUMORS
$504,772David Reardon · Duke University · P50 · FY2011 · NS
Effect of Bone Marrow Cells on the Radiosensitivity of Brain and Mouth Cancers
$504,695John Martin Brown · Stanford University · R01 · FY2009 · CA
Investigate the role of EGFR and PDGFR regulated pathways in GBM tumorigenesis
$504,593Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Mechanisms of Biguanide Sensitivity in GBM
$504,183Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · NS
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors
$504,105Justin S. Hanes · Johns Hopkins University · R01 · FY2020 · CA
Targeting epigenetic reader GAS41
$504,038Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Therapeutic targeting of the SWI/SNF chromatin remodeler to regulate GBM chemosensitivity
$504,020Lawrence M Pfeffer · University Of Tennessee Health Sci Ctr · R01 · FY2023 · CA
Allergic Condition Susceptibility Polymorphisms and Glioma Risk
$504,006Judith Schwartzbaum · Ohio State University · R01 · FY2011 · CA
Monoclonal Antibody to FGF2 for Treatment of Hepatocellular Carcinoma and Other C
$504,006K Jin Kim · Galaxy Biotech, Llc · R44 · FY2012 · CA
Imaging Brain Metabolism Using MRS of Hyperpolarized 13C-Pyruvate
$504,002Daniel M Spielman · Stanford University · R01 · FY2017 · EB
Magnetic-vortex microdiscs for glioma therapy
$503,933Maciej S Lesniak · University Of Chicago · R01 · FY2014 · NS
Utility and Application of Unsaturated Acylammonium Salts in Organic Synthesis
$503,790Daniel Romo · Baylor University · · FY2018 · MPS
AHR-mediated immunosuppression in glioblastoma
$503,741Francisco J. Quintana · Brigham And Women'S Hospital · R01 · FY2019 · ES
CAREER: MOEMS-based Head-mounted NIR-II Microscopy for Molecular Imaging of Brain Tumor in Freely Behaving Small Animal Models
$503,644Wen Li · Michigan State University · · FY2023 · ENG
Radiogenomics Framework for Non-Invasive Personalized Medicine
$503,635Olivier Gevaert · Stanford University · R01 · FY2017 · EB
Proj. 1 Targeting Tumor-Specific Neoepitopes for Glioblastoma Immunotherapy
$503,520David Reardon · Brigham And Women'S Hospital · P01 · FY2024 · CA
Computational Approaches for RNA StructureFunction Determination
$503,448Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
âPharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment responseâ
$503,363Robert C Rostomily · Methodist Hospital Research Institute · R01 · FY2023 · NS
Resource Core II: In Vivo Core
$503,215Victor Steven Van Laar · University Of California Berkeley · U19 · FY2024 · NS
Assessing the efficacy of a ROR1:PD-L1:CD2 multispecific T cell engager in ROR1-positive and -negative neuroblastoma models
$503,194James M Olson · Seattle Children'S Hospital · R21 · FY2024 · CA
Self-Assembling Camptothecin Nanofiber Hydrogels as Adjunct Therapy for Intraoperative Treatment of Malignant Glioma
$502,940Honggang Cui · Johns Hopkins University · R01 · FY2024 · CA
Stress responses in embryonic stem cells
$502,812Jing Huang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses to hirsutinolides
$502,653James K Turkson · University Of Hawaii At Manoa · R01 · FY2018 · CA
CHI3L1-targeted small molecules for glioblastoma
$502,588Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · NS
CHI3L1-targeted small molecules for glioblastoma
$502,588Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS